Role of nitric oxide synthases in Parkinson's disease: A review on the antioxidant and anti-inflammatory activity of polyphenols

Neurochemical Research

Volumn 33, Issue 12, 2008, Pages 2416-2426

  Aquilano, Katia ^a,b   Baldelli, Sara ^a   Rotilio, Giuseppe ^a,b   Ciriolo, Maria Rosa ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Anti oxidants; Inflammation; Nitric oxide; Oxidative stress; Parkinson's disease; Polyphenols

Indexed keywords

CATECHIN; CURCUMIN; NITRIC OXIDE SYNTHASE; POLYPHENOL; RESVERATROL;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; DRUG ACTIVITY; DRUG STRUCTURE; HUMAN; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SUBSTANTIA NIGRA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; FLAVONOIDS; HUMANS; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PARKINSON DISEASE; PHENOLS;

ANIMALIA;

EID: 56349089470     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9697-6     Document Type: Review

References (113)

1. MN Clifford 2004 Diet-derived phenols in plasma and tissues and their implications for health Planta Med 70 1103 1114
2. GR Beecher 2003 Overview of dietary flavonoids: nomenclature, occurrence and intake J Nutr 133 3248S 3254S
3. E Middleton Jr C Kandaswami TC Theoharides 2000 The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer Pharmacol Rev 52 673 751
4. S Rotondo G de Gaetano 2000 Protection from cardiovascular disease by wine and its derived products. Epidemiological evidence and biological mechanisms World Rev Nutr Diet 87 90 113
5. C Ramassamy 2006 Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets Eur J Pharmacol 545 51 64
6. S Schaffer GP Eckert S Schmitt-Schillig WE Muller 2006 Plant foods and brain aging: a critical appraisal Forum Nutr 59 86 115
7. LM Wee LH Long M Whiteman B Halliwell 2003 Factors affecting the ascorbate- and phenolic-dependent generation of hydrogen peroxide in Dulbecco's Modified Eagles Medium Free Radic Res 37 1123 1130
8. CA de la Lastra I Villegas 2007 Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications Biochem Soc Trans 35 1156 1160
9. KW Lee HJ Lee 2006 The roles of polyphenols in cancer chemoprevention Biofactors 26 105 121
10. B Frei JV Higdon 2003 Antioxidant activity of tea polyphenols in vivo: evidence from animal studies J Nutr 133 3275S 3284S
11. KE Heim AR Tagliaferro DJ Bobilya 2002 Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships J Nutr Biochem 13 572 584
12. T Nakagawa T Yokozawa 2002 Direct scavenging of nitric oxide and superoxide by green tea Food Chem Toxicol 40 1745 1750
13. MP Mattson T Magnus 2006 Ageing and neuronal vulnerability Nat Rev Neurosci 7 278 294
14. RL Mosley EJ Benner I Kadiu 2006 Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease Clin Neurosci Res 6 261 281
15. C Manach A Scalbert C Morand 2004 Polyphenols: food sources and bioavailability Am J Clin Nutr 79 727 747
16. S Mandel T Amit L Reznichenko 2006 Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders Mol Nutr Food Res 50 229 234
17. KA Youdim B Shukitt-Hale JA Joseph 2004 Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system Free Radic Biol Med 37 1683 1693
18. M Mokni S Elkahoui F Limam 2007 Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat Neurochem Res 32 981 987
19. S Mandel O Weinreb T Amit MB Youdim 2004 Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3- gallate: implications for neurodegenerative diseases J Neurochem 88 1555 1569
20. R Masella R Di Benedetto R Vari 2005 Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes J Nutr Biochem 16 577 586
21. HP Kim KH Son HW Chang SS Kang 2004 Anti-inflammatory plant flavonoids and cellular action mechanisms J Pharmacol Sci 96 229 245
22. P Lorenz S Roychowdhury M Engelmann 2003 Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells Nitric Oxide 9 64 76
23. FC Lau B Shukitt-Hale JA Joseph 2005 The beneficial effects of fruit polyphenols on brain aging Neurobiol Aging 26 Suppl 1 128 132
24. E Esposito D Rotilio V Di Matteo 2002 A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes Neurobiol Aging 23 719 735
25. CW Olanow WG Tatton 1999 Etiology and pathogenesis of Parkinson's disease Annu Rev Neurosci 22 123 144
26. PM Kidd 2000 Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management Altern Med Rev 5 502 529
27. P Jenner 2003 Oxidative stress in Parkinson's disease Ann Neurol 53 Suppl 3 S26 S36 discussion S36-S28
28. PS Whitton 2007 Inflammation as a causative factor in the aetiology of Parkinson's disease Br J Pharmacol 150 963 976
29. R Betarbet TB Sherer G MacKenzie 2000 Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat Neurosci 3 1301 1306
30. M Thiruchelvam BJ Brockel EK Richfield 2000 Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Res 873 225 234
31. M Thiruchelvam EK Richfield RB Baggs 2000 The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease J Neurosci 20 9207 9214
32. MK Lee SJ Kang M Poncz 2007 Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine Exp Mol Med 39 376 384
33. S Dore 2005 Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity Neurosignals 14 61 70
34. S Guo E Bezard B Zhao 2005 Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway Free Radic Biol Med 39 682 695
35. O Weinreb S Mandel T Amit MB Youdim 2004 Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases J Nutr Biochem 15 506 516
36. AH Schapira 2006 Etiology of Parkinson's disease Neurology 66 S10 S23
37. AH Schapira 2007 Mitochondrial dysfunction in Parkinson's disease Cell Death Differ 14 1261 1266
38. AH Schapira 2008 Mitochondria in the aetiology and pathogenesis of Parkinson's disease Lancet Neurol 7 97 109
39. R Shukla M Rajani N Srivastava 2006 Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease Int J Neurosci 116 1391 1402
40. JA Molina FJ Jimenez-Jimenez JA Navarro 1996 Cerebrospinal fluid nitrate levels in patients with Parkinson's disease Acta Neurol Scand 93 123 126
41. L Zhang VL Dawson TM Dawson 2006 Role of nitric oxide in Parkinson's disease Pharmacol Ther 109 33 41
42. R Kavya R Saluja S Singh M Dikshit 2006 Nitric oxide synthase regulation and diversity: implications in Parkinson's disease Nitric Oxide 15 280 294
43. WK Alderton CE Cooper RG Knowles 2001 Nitric oxide synthases: structure, function and inhibition Biochem J 357 593 615
44. AG Estevez N Spear JA Thompson 1998 Nitric oxide-dependent production of cGMP supports the survival of rat embryonic motor neurons cultured with brain-derived neurotrophic factor J Neurosci 18 3708 3714
45. RN Saha K Pahan 2006 Regulation of inducible nitric oxide synthase gene in glial cells Antioxid Redox Signal 8 929 947
46. Z Lacza E Pankotai A Csordas 2006 Mitochondrial NO and reactive nitrogen species production: does mtNOS exist? Nitric Oxide 14 162 168
47. MC Carreras MC Franco JG Peralta JJ Poderoso 2004 Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease Mol Aspects Med 25 125 139
48. C Giulivi K Kato CE Cooper 2006 Nitric oxide regulation of mitochondrial oxygen consumption I: cellular physiology Am J Physiol Cell Physiol 291 C1225 C1231
49. S Hunot F Boissiere B Faucheux 1996 Nitric oxide synthase and neuronal vulnerability in Parkinson's disease Neuroscience 72 355 363
50. DJ Eve AP Nisbet AE Kingsbury 1998 Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease Brain Res Mol Brain Res 63 62 71
51. Y Muramatsu R Kurosaki H Watanabe 2003 Cerebral alterations in a MPTP-mouse model of Parkinson's disease-an immunocytochemical study J Neural Transm 110 1129 1144
52. M Chalimoniuk J Langfort N Lukacova J Marsala 2004 Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice Biochem Biophys Res Commun 324 118 126
53. B Cutillas M Espejo J Gil 1999 Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration Neuroreport 10 2605 2608
54. JB Schulz RT Matthews MM Muqit 1995 Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice J Neurochem 64 936 939
55. P Hantraye E Brouillet R Ferrante 1996 Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons Nat Med 2 1017 1021
56. MF Beal 1998 Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis Ann Neurol 44 S110 S114
57. PK Kim R Zamora P Petrosko TR Billiar 2001 The regulatory role of nitric oxide in apoptosis Int Immunopharmacol 1 1421 1441
58. AS Mandir S Przedborski V Jackson-Lewis 1999 Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism Proc Natl Acad Sci USA 96 5774 5779
59. S Pennathur V Jackson-Lewis S Przedborski JW Heinecke 1999 Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease J Biol Chem 274 34621 34628
60. RJ Ferrante P Hantraye E Brouillet MF Beal 1999 Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase Brain Res 823 177 182
61. PF Good A Hsu P Werner 1998 Protein nitration in Parkinson's disease J Neuropathol Exp Neurol 57 338 342
62. BI Giasson IV Murray JQ Trojanowski VM Lee 2001 A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly J Biol Chem 276 2380 2386
63. K Beyer 2007 Mechanistic aspects of Parkinson's disease: alpha-synuclein and the biomembrane Cell Biochem Biophys 47 285 299
64. DT Hess A Matsumoto R Nudelman JS Stamler 2001 S-nitrosylation: spectrum and specificity Nat Cell Biol 3 E46 E49
65. DT Hess A Matsumoto SO Kim 2005 Protein S-nitrosylation: purview and parameters Nat Rev Mol Cell Biol 6 150 166
66. T Uehara T Nakamura D Yao 2006 S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration Nature 441 513 517
67. SA Lipton Z Gu T Nakamura 2007 Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders Int Rev Neurobiol 82 1 27
68. KK Chung VL Dawson TM Dawson 2005 S-nitrosylation in Parkinson's disease and related neurodegenerative disorders Methods Enzymol 396 139 150
69. KK Chung B Thomas X Li 2004 S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function Science 304 1328 1331
70. M Brunori E Forte M Arese 2006 Nitric oxide and the respiratory enzyme Biochim Biophys Acta 1757 1144 1154
71. S Moncada 2000 Nitric oxide and cell respiration: physiology and pathology Verh K Acad Geneeskd Belg 62 171 179 discussion 179-181
72. MO Lopez-Figueroa C Caamano MI Morano 2000 Direct evidence of nitric oxide presence within mitochondria Biochem Biophys Res Commun 272 129 133
73. A Kanai M Epperly L Pearce 2004 Differing roles of mitochondrial nitric oxide synthase in cardiomyocytes and urothelial cells Am J Physiol Heart Circ Physiol 286 H13 H21
74. C Giulivi 2007 Mitochondria as generators and targets of nitric oxide Novartis Found Symp 287 92 100 discussion 100-104
75. HM Gao JS Hong W Zhang B Liu 2002 Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons J Neurosci 22 782 790
76. Y He S Appel W Le 2001 Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum Brain Res 909 187 193
77. HM Gao B Liu W Zhang JS Hong 2003 Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease Faseb J 17 1954 1956
78. H Wilms L Zecca P Rosenstiel 2007 Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications Curr Pharm Des 13 1925 1928
79. C Knott G Stern GP Wilkin 2000 Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2 Mol Cell Neurosci 16 724 739
80. C Mancuso G Scapagini D Curro 2007 Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders Front Biosci 12 1107 1123
81. GT Liberatore V Jackson-Lewis S Vukosavic 1999 Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease Nat Med 5 1403 1409
82. J Chen C Wersinger A Sidhu 2003 Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity J Biol Chem 278 28089 28100
83. DW Reif RD Simmons 1990 Nitric oxide mediates iron release from ferritin Arch Biochem Biophys 283 537 541
84. JB Schulz MF Beal 1995 Neuroprotective effects of free radical scavengers and energy repletion in animal models of neurodegenerative disease Ann N Y Acad Sci 765 100 110 discussion 116-108
85. F Nanjo M Honda K Okushio 1993 Effects of dietary tea catechins on alpha-tocopherol levels, lipid peroxidation, and erythrocyte deformability in rats fed on high palm oil and perilla oil diets Biol Pharm Bull 16 1156 1159
86. Q Guo B Zhao S Shen 1999 ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers Biochim Biophys Acta 1427 13 23
87. GR Haenen JB Paquay RE Korthouwer A Bast 1997 Peroxynitrite scavenging by flavonoids Biochem Biophys Res Commun 236 591 593
88. CG Heijnen GR Haenen FA van Acker 2001 Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups Toxicol In Vitro 15 3 6
89. JB Paquay GR Haenen G Stender 2000 Protection against nitric oxide toxicity by tea J Agric Food Chem 48 5768 5772
90. LD Mercer BL Kelly MK Horne PM Beart 2005 Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures Biochem Pharmacol 69 339 345
91. G Lopez-Lopez L Moreno A Cogolludo 2004 Nitric oxide (NO) scavenging and NO protecting effects of quercetin and their biological significance in vascular smooth muscle Mol Pharmacol 65 851 859
92. T Yokozawa DY Rhyu EJ Cho 2004 (-)-Epicatechin 3-O-gallate ameliorates the damages related to peroxynitrite production by mechanisms distinct from those of other free radical inhibitors J Pharm Pharmacol 56 231 239
93. S Mandel MB Youdim 2004 Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases Free Radic Biol Med 37 304 317
94. KT Lu RY Chiou LG Chen 2006 Neuroprotective effects of resveratrol on cerebral ischemia-induced neuron loss mediated by free radical scavenging and cerebral blood flow elevation J Agric Food Chem 54 3126 3131
95. U Sonmez A Sonmez G Erbil 2007 Neuroprotective effects of resveratrol against traumatic brain injury in immature rats Neurosci Lett 420 133 137
96. S Bastianetto WH Zheng R Quirion 2000 Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons Br J Pharmacol 131 711 720
97. M Virgili A Contestabile 2000 Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats Neurosci Lett 281 123 126
98. 2+ concentrations are involved in resveratrol protection against apoptosis in rat primary neuron cultures Acta Pharmacol Sin 28 1724 1730
99. G Rotilio K Aquilano MR Ciriolo 2003 Interplay of Cu, Zn superoxide dismutase and nitric oxide synthase in neurodegenerative processes IUBMB Life 55 629 634
100. L Amazzal A Lapotre F Quignon D Bagrel 2007 Mangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells Neurosci Lett 418 159 164
101. G Martinez A Giuliani OS Leon 2001 Effect of Mangifera indica L. extract (QF808) on protein and hepatic microsome peroxidation Phytother Res 15 581 585
102. 2+-citrate Eur J Pharmacol 513 47 55
103. KL Liu HW Chen RY Wang 2006 DATS reduces LPS-induced iNOS expression, NO production, oxidative stress, and NF-kappaB activation in RAW 264.7 macrophages J Agric Food Chem 54 3472 3478
104. Y Geng B Zhang M Lotz 1993 Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes J Immunol 151 6692 6700
105. D Kempuraj B Madhappan S Christodoulou 2005 Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells Br J Pharmacol 145 934 944
106. TL Wadsworth TL McDonald DR Koop 2001 Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha Biochem Pharmacol 62 963 974
107. J Baumann G Wurm F von Bruchhausen 1980 Prostaglandin synthetase inhibition by flavonoids and phenolic compounds in relation to their O2-scavenging properties (author's transl) Arch Pharm (Weinheim) 313 330 337
108. YC Liang YT Huang SH Tsai 1999 Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages Carcinogenesis 20 1945 1952
109. JL Pang DA Ricupero S Huang 2006 Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells Biochem Pharmacol 71 818 826
110. BS Cheon YH Kim KS Son 2000 Effects of prenylated flavonoids and biflavonoids on lipopolysaccharide-induced nitric oxide production from the mouse macrophage cell line RAW 264.7 Planta Med 66 596 600
111. Y Chen L Yang TJ Lee 2000 Oroxylin A inhibition of lipopolysaccharide- induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation Biochem Pharmacol 59 1445 1457
112. KA Youdim JA Joseph 2001 A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects Free Radic Biol Med 30 583 594
113. MM Abd El Mohsen G Kuhnle AR Rechner 2002 Uptake and metabolism of epicatechin and its access to the brain after oral ingestion Free Radic Biol Med 33 1693 1702